ThinkSabio

$ODTX

$17.80▲ -2.0% YTD

5 SEC 13D/G filings tracked · Last updated Oct 20, 2026

Filing History
News
ODTX ▼ -2.0% - Odyssey Therapeutics, Inc.
CP $17.80▲ -2.0%Oct 20, 2026 · ThinkSabio Blog

$ODTX Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026…

News
ODTX ▼ -2.0% - Odyssey Therapeutics, Inc.
CP $17.80▲ -2.0%Oct 20, 2026 · ThinkSabio Blog

$ODTX - Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026…

News
ODTX ▼ -0.3% - Odyssey Therapeutics, Inc.
CP $19.00▲ -0.3%Oct 12, 2026 · ThinkSabio Blog

$ODTX - Odyssey Therapeutics to Present Design of Phase 2a Study Evaluating OD-001 in Combination with Vedolizumab at ACG 2026…

News
ODTX ▼ -0.6% - Odyssey Therapeutics, Inc.
CP $20.84▲ -0.6%Oct 6, 2026 · ThinkSabio Blog

$ODTX - Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026…

News
ODTX ▼ -2.7% - Odyssey Therapeutics, Inc.
CP $21.40▲ -2.7%Sep 16, 2026 · ThinkSabio Blog

$ODTX - Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum…